Eton Pharmaceuticals/$ETON
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Eton Pharmaceuticals
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
Ticker
$ETON
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
31
ISIN
US29772L1089
Website
ETON Metrics
BasicAdvanced
$507M
-
-$0.18
-
-
Price and volume
Market cap
$507M
52-week high
$21.48
52-week low
$3.18
Average daily volume
314K
Financial strength
Current ratio
1.971
Quick ratio
1.334
Long term debt to equity
123.022
Total debt to equity
123.022
Interest coverage (TTM)
-0.61%
Management effectiveness
Return on assets (TTM)
-2.02%
Return on equity (TTM)
-22.95%
Valuation
Price to revenue (TTM)
10.248
Price to book
20.75
Price to tangible book (TTM)
-53.81
Price to free cash flow (TTM)
-190.48
Growth
Revenue change (TTM)
40.88%
Earnings per share change (TTM)
-642.83%
3-year revenue growth (CAGR)
58.61%
3-year earnings per share growth (CAGR)
-28.52%
What the Analysts think about ETON
Analyst ratings (Buy, Hold, Sell) for Eton Pharmaceuticals stock.
ETON Financial Performance
Revenues and expenses
ETON Earnings Performance
Company profitability
ETON News
AllArticlesVideos
FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue
Benzinga·1 day ago
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
GlobeNewsWire·2 days ago
Eton Pharmaceuticals Set To Dominate Orphan Drug Niche
Seeking Alpha·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Eton Pharmaceuticals stock?
Eton Pharmaceuticals (ETON) has a market cap of $507M as of May 30, 2025.
What is the P/E ratio for Eton Pharmaceuticals stock?
The price to earnings (P/E) ratio for Eton Pharmaceuticals (ETON) stock is 0 as of May 30, 2025.
Does Eton Pharmaceuticals stock pay dividends?
No, Eton Pharmaceuticals (ETON) stock does not pay dividends to its shareholders as of May 30, 2025.
When is the next Eton Pharmaceuticals dividend payment date?
Eton Pharmaceuticals (ETON) stock does not pay dividends to its shareholders.
What is the beta indicator for Eton Pharmaceuticals?
Eton Pharmaceuticals (ETON) does not currently have a Beta indicator.